Renaissance Technologies’s Eterna Therapeutics ERNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-672
Closed -$24K 3609
2024
Q1
$24K Buy
+672
New +$24K ﹤0.01% 3573
2023
Q2
Sell
-870
Closed -$44K 4017
2023
Q1
$44K Sell
870
-299
-26% -$15.1K ﹤0.01% 3686
2022
Q4
$56K Sell
1,169
-3,696
-76% -$177K ﹤0.01% 3777
2022
Q3
$360K Buy
4,865
+812
+20% +$60.1K ﹤0.01% 3112
2022
Q2
$629K Buy
4,053
+2,112
+109% +$328K ﹤0.01% 3015
2022
Q1
$1.19M Buy
1,941
+949
+96% +$584K ﹤0.01% 2616
2021
Q4
$1.24M Buy
+992
New +$1.24M ﹤0.01% 2490
2021
Q2
Sell
-66
Closed -$74K 3537
2021
Q1
$74K Buy
+66
New +$74K ﹤0.01% 3236
2020
Q4
Sell
-164
Closed -$167K 3462
2020
Q3
$167K Sell
164
-28
-15% -$28.5K ﹤0.01% 3143
2020
Q2
$253K Buy
192
+89
+86% +$117K ﹤0.01% 3097
2020
Q1
$94K Buy
103
+4
+4% +$3.65K ﹤0.01% 3239
2019
Q4
$131K Buy
99
+3
+3% +$3.97K ﹤0.01% 3266
2019
Q3
$193K Buy
96
+5
+5% +$10.1K ﹤0.01% 3159
2019
Q2
$206K Buy
91
+8
+10% +$18.1K ﹤0.01% 3297
2019
Q1
$201K Buy
83
+7
+9% +$17K ﹤0.01% 3210
2018
Q4
$89K Sell
76
-5
-6% -$5.86K ﹤0.01% 3245
2018
Q3
$215K Hold
81
﹤0.01% 3130
2018
Q2
$216K Hold
81
﹤0.01% 3060
2018
Q1
$332K Buy
81
+4
+5% +$16.4K ﹤0.01% 3041
2017
Q4
$194K Buy
77
+5
+7% +$12.6K ﹤0.01% 3142
2017
Q3
$265K Buy
72
+3
+4% +$11K ﹤0.01% 2934
2017
Q2
$283K Buy
69
+12
+21% +$49.2K ﹤0.01% 2919
2017
Q1
$294K Buy
57
+15
+36% +$77.4K ﹤0.01% 2911
2016
Q4
$214K Buy
42
+7
+20% +$35.7K ﹤0.01% 2984
2016
Q3
$148K Buy
35
+4
+13% +$16.9K ﹤0.01% 3125
2016
Q2
$158K Buy
31
+3
+11% +$15.3K ﹤0.01% 3092
2016
Q1
$124K Buy
28
+1
+4% +$4.43K ﹤0.01% 3178
2015
Q4
$130K Hold
27
﹤0.01% 3080
2015
Q3
$268K Buy
27
+1
+4% +$9.93K ﹤0.01% 2809
2015
Q2
$182K Hold
26
﹤0.01% 2999
2015
Q1
$326K Hold
26
﹤0.01% 2736
2014
Q4
$345K Hold
26
﹤0.01% 2537
2014
Q3
$258K Hold
26
﹤0.01% 2512
2014
Q2
$408K Buy
26
+1
+4% +$15.7K ﹤0.01% 2389
2014
Q1
$481K Buy
25
+1
+4% +$19.2K ﹤0.01% 2370
2013
Q4
$451K Buy
24
+1
+4% +$18.8K ﹤0.01% 2385
2013
Q3
$239K Buy
23
+1
+5% +$10.4K ﹤0.01% 2521
2013
Q2
$274K Buy
+22
New +$274K ﹤0.01% 2427